Abstract
Purpose
To assess the long-term malignancy risk of incidental small pancreatic cysts.
Materials and methods
In this HIPAA-compliant, IRB-approved, retrospective, multi-institutional study, the long-term incidence of pancreatic cancer was compared between patients with and without small pancreatic cysts. Patients with incidental pancreatic cysts ≥ 0.5 and < 2.0 cm in maximal diameter, detected on MRI performed between 1999 and 2011, represented the “small pancreatic cyst” group. Patients that underwent MRI between 2005 and 2011 and had no reported pancreatic cysts represented the comparison “no cyst” group.
Results
The “small pancreatic cyst” group included 267 patients, ages 63.4 ± 11.8 years, 166/267 (62%) women with a mean follow-up of 8.6 ± 4.3 years, median 9.2 years; the “no cyst” group included 1,459 patients, ages 64.6 ± 12 years, 794/1,459 (54%) women with a mean follow-up of 7.0 ± 4.2 years, median 7.8 (p values 0.12, 0.02, < 0.001, respectively). Two/267 (0.7%) patients developed pancreatic cancer at a separate location from the known cyst in the “small pancreatic cyst” group, with a cancer rate of 0.9 (95% CI 0.1–3.1) cases per 1,000 patient-years. In the “no cyst” cohort, 18/1,459 (1.2%) patients developed pancreatic cancer, with a cancer rate of 1.8 (95% CI 1.2–3.1) cases per 1,000 patient-years (p = 0.6). The all-cause mortality was similar in both groups: 57/267 (21%) vs. 384/1,459 (26%) (p = 0.09).
Conclusion
The long-term risk of pancreatic malignancy in asymptomatic patients with incidental pancreatic cysts less than 2 cm is 0.9 cases per 1,000 patient-years of follow-up, similar to those without pancreatic cysts. These very few pancreatic cancers developed at a separate location from the known cyst.
Key Points
• After a median of 9.2 years of follow-up, the risk of pancreatic malignancy in patients with an asymptomatic small pancreatic cyst was 0.9 cases per 1,000 patient-years of follow-up, similar to those without pancreatic cysts.
• Very few pancreatic cancer cases developed in the location separate from the known pancreatic cyst.
Similar content being viewed by others
Abbreviations
- CI:
-
Confidence interval
- IPMN:
-
Intraductal papillary mucinous neoplasm
- IQR:
-
Interquartile range
References
Kromrey ML, Bülow R, Hübner J et al (2018) Prospective study on the incidence, prevalence and 5-year pancreatic-related mortality of pancreatic cysts in a population-based study. Gut 67:138–145
Chernyak V, Flusberg M, Haramati LB, Rozenblit AM, Bellin E (2015) Incidental pancreatic cystic lesions: is there a relationship with the development of pancreatic adenocarcinoma and all-cause mortality? Radiology 274:161–169
Moris M, Bridges MD, Pooley RA et al (2016) Association between advances in high-resolution cross-section imaging technologies and increase in prevalence of pancreatic cysts from 2005 to 2014. Clin Gastroenterol Hepatol 14:585-593.e3
Brook OR, Beddy P, Pahade J et al (2016) Delayed growth in incidental pancreatic cysts: are the current American College of Radiology recommendations for follow-up appropriate? Radiology 278:752–761
Assarzadegan N, Thompson E, Salimian K, et al (2021) Pathology of intraductal papillary mucinous neoplasms. Langenbeck’s Arch Surg. doi:https://doi.org/10.1007/s00423-021-02201-0.
Yamada Y, Mori H, Matsumoto S, Kamei N, Hongo N (2006) Invasive carcinomas derived from intraductal papillary mucinous neoplasms of the pancreas: a long-term follow-up assessment with CT imaging. J Comput Assist Tomogr 30:885–890
Tanaka M, Fernández-del Castillo C, Adsay V et al (2012) International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology 12:183–197
Tanaka M, Fernández-del Castillo C, Kamisawa T et al (2017) Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. Pancreatology 17:738–753
Megibow AJ, Baker ME, Morgan DE et al (2017) Management of incidental pancreatic cysts: a white paper of the ACR Incidental Findings Committee. J Am Coll Radiol 14:911–923
Vege SS, Ziring B, Jain R, Moayyedi P, Clinical Guidelines Committee, American Gastroenterology Association (2015) American Gastroenterological Association Institute guideline on the diagnosis and management of asymptomatic neoplastic pancreatic cysts. Gastroenterology 148:819–822
Elta GH, Enestvedt BK, Sauer BG, Lennon AM (2018) ACG Clinical Guideline: diagnosis and management of pancreatic cysts. Am J Gastroenterol 113:464–479
Del Chiaro M, Besselink MG, Scholten L et al (2018) European evidence-based guidelines on pancreatic cystic neoplasms. Gut 67:789–804
Dunn DP, Brook OR, Brook A et al (2016) Measurement of pancreatic cystic lesions on magnetic resonance imaging: efficacy of standards in reducing inter-observer variability. Abdom Radiol (NY) 41:500–507
Hecht EM, Khatri G, Morgan D et al (2021) Intraductal papillary mucinous neoplasm (IPMN) of the pancreas: recommendations for Standardized Imaging and Reporting from the Society of Abdominal Radiology IPMN disease focused panel. Abdom Radiol (NY) 46:1586–1606
Malleo G, Marchegiani G, Borin A et al (2015) Observational study of the incidence of pancreatic and extrapancreatic malignancies during surveillance of patients with branch-duct intraductal papillary mucinous neoplasm. Ann Surg 261:984–990
Nagata N, Kawazoe A, Mishima S et al (2016) Development of pancreatic cancer, disease-specific mortality, and all-cause mortality in patients with nonresected IPMNs: a long-term cohort study. Radiology 278:125–134
Choi SH, Park SH, Kim KW, Lee JY, Lee SS (2017) Progression of unresected intraductal papillary mucinous neoplasms of the pancreas to cancer: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 15:1509–1520.e4
Nguyen AH, Toste PA, Farrell JJ et al (2015) Current recommendations for surveillance and surgery of intraductal papillary mucinous neoplasms may overlook some patients with cancer. J Gastrointest Surg 19:258–265
Handrich SJ, Hough DM, Fletcher JG, Sarr MG (2005) The natural history of the incidentally discovered small simple pancreatic cyst: long-term follow-up and clinical implications. AJR Am J Roentgenol 184:20–23
Kayal M, Luk L, Hecht EM et al (2017) Long-term surveillance and timeline of progression of presumed low-risk intraductal papillary mucinous neoplasms. AJR Am J Roentgenol 209:320–326
Lawrence SA, Attiyeh MA, Seier K et al (2017) Should patients with cystic lesions of the pancreas undergo long-term radiographic surveillance?: results of 3024 patients evaluated at a single institution. Ann Surg 266:536–544
Pergolini I, Sahora K, Ferrone CR et al (2017) Long-term risk of pancreatic malignancy in patients with branch duct intraductal papillary mucinous neoplasm in a referral center. Gastroenterology 153:1284-1294.e1
Han Y, Lee H, Kang JS et al (2018) Progression of pancreatic branch duct intraductal papillary mucinous neoplasm associates with cyst size. Gastroenterology 154:576–584
Pandey P, Pandey A, Luo Y et al (2019) Follow-up of incidentally detected pancreatic cystic neoplasms: do baseline MRI and CT features predict cyst growth? Radiology 292:647–654
Martínez B, Martínez JF, Aparicio JR (2018) Prevalence of incidental pancreatic cyst on upper endoscopic ultrasound. Ann Gastroenterol 31:90–95
Farrell JJ (2015) Prevalence, diagnosis and management of pancreatic cystic neoplasms: current status and future directions. Gut Liver 9:571–589
Lowenfels AB, Maisonneuve P, Cavallini G et al (1993) Pancreatitis and the risk of pancreatic cancer. N Engl J Med 328:1433–1437
Yadav D, Lowenfels A (2013) The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology 144:1252–1261
Pickhardt P, Graffy P, Zea R et al (2020) Automated CT biomarkers for opportunistic prediction of future cardiovascular events and mortality in an asymptomatic screening population: a retrospective cohort study. Lancet Digit Heal 2:e192–e200
Funding
The authors state that this work has not received any funding.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Guarantor
The scientific guarantor of this publication is Olga R. Brook.
Conflict of interest
The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.
Statistics and biometry
One of the authors has significant statistical expertise.
Informed consent
Written informed consent was waived by the Institutional Review Board.
Ethical approval
Institutional Review Board approval was obtained.
Study subjects or cohorts overlap
Earlier results of two cohorts were previously reported in the following:
Brook OR, Beddy P, Pahade J, et al. Delayed growth in incidental pancreatic cysts: Are the current American College of Radiology recommendations for follow-up appropriate? Radiology; 2016;278(3):752–761.
Chernyak V, Flusberg M, Haramati LB, Rozenblit AM, Bellin E. Incidental pancreatic cystic lesions: is there a relationship with the development of pancreatic adenocarcinoma and all-cause mortality? Radiology. 2015;274(1):161–169.
This study demonstrates long-term follow-up on the same patients.
Methodology
• retrospective
• case-control study
• multicenter study
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Nakhaei, M., Bligh, M., Chernyak, V. et al. Incidence of pancreatic cancer during long-term follow-up in patients with incidental pancreatic cysts smaller than 2 cm. Eur Radiol 32, 3369–3376 (2022). https://doi.org/10.1007/s00330-021-08428-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-021-08428-1